Skip to main content
OpenTrials
Completed

NCT Number: NCT05940688

Providing an Optimized and emPowered Pregnancy for You (PᵌOPPY) Feasibility Study

The P3OPPY Project is one of five projects within the American Heart Association P3 EQUATE Network. The overarching goal of the P3 EQUATE American Heart Association Health Equity Research Network (HERN) is to promote equity in Maternal and Infant Health outcomes by identifying innovative and cost-effective strategies to enhance access to quality health information, care, and experiences during pregnancy, postnatal and postpartum/preconception periods, particularly for Black and under-served populations. Collectively, the investigators will collaborate with pregnant and postpartum individuals and their families, hospitals, and communities to discover ways to reduce racism and social problems that contribute to poor health outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–49 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

About this study

Feasibility Study Aims

  • To assess the feasibility of the digital health (DHI) and community health worker (CHW) interventions by assessing participant acceptance and use of the intervention.
  • To assess study enrollment to determine appropriateness and usefulness of the inclusion and exclusion criteria to estimate enrollment duration in the planned trial.
  • To determine the number of prenatal visits and the incidence of some of the maternal and neonatal outcomes (ones with higher prevalence) or surrogate outcomes that will be targeted in the planned factorial design randomized controlled trial. (Data will be collected on all relevant maternal and neonatal outcomes. The randomized feasibility design will allow for effect size estimates of the intervention on the incidence of maternal and neonatal outcomes, which will aid in determining the appropriate target outcomes as well as power calculation of the more definitive trial.)

The PᵌOPPY study is designed to support the American Heart Association's mission to improve maternal/infant health outcomes and address inequities in maternal/infant health care. The promise of digital health and community health worker engagement makes PᵌOPPY interventions potentially transformative, sustainable, and scalable for Non-Hispanic Black mothers and their infants from under-served communities in Alabama and beyond. The objective of this pilot study is to determine if it is feasible to randomize and implement digital health and community health worker interventions.

Design Summary

The investigators will challenge existing care paradigms by testing the effectiveness of integrating innovative platforms into the existing healthcare system, including existing digital health and community health worker programs from within the EQUATE consortium, to eliminate critical barriers to equitable healthcare access. After seeking input from a Community Advisory Board, these interventions will be refined and deployed for pilot testing. Individuals in Non-Hispanic Black communities at the highest risk of adverse pregnancy outcomes which were historically underrepresented in clinical research due to structural racism will be included. The investigative team employs experts across the community, maternal, and infant health continuum.

For this pilot, 40 eligible participants will be randomized, 10 to usual care, 10 to DHI, 10 to CHW, and 10 to DHI + CHW

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Self Identifies as Non-Hispanic Black
  • Between 16-49 years old
  • Pregnant individuals between 8⁰ - 22⁶ weeks gestational age
  • Live singleton or dichorionic twin gestation
  • Dating sonogram at <23 weeks gestation
  • Area Deprivation Index (ADI) National 4th or 5th Quintile
  • Planning to deliver at UAB Hospital
  • Speaks and writes in English
  • No indication for delivery at the time of enrollment

Exclusion criteria

  • Declines randomization
  • Speaks or writes in languages other than English
  • Currently incarcerated
  • Fetal demise diagnosed prior to enrollment
  • Known major structural chromosomal abnormalities prior to enrollment

Treatment and study plan

Digital Health Intervention

Behavioral

Health care information delivered via a link in a text message that is then opened in a secure browser.

Other names: DHI

Community health worker

Behavioral

Health care information delivered via CHW.

Other names: CHW

Digital Health Intervention plus Community Health Worker

Behavioral

Health care information delivered via DHI plus CHW

Primary outcomes

  1. Participant Acceptance of Randomization Arm / Intervention

    Time frame: 6 weeks postpartum

    Participant acceptance is defined as a yes response to this question:

    "I would recommend the care I received to someone in a similar situation."

  2. Participant Use of Digital Health and/or Community Health Worker Interventions

    Time frame: From randomization to 6 weeks postpartum

    Use of the intervention for the digital health arm(s) is defined as the % of opened text messages. Use of the intervention for the community health worker arm(s) is defined as the % of planned sessions in which the participant engages with the community health worker.

Secondary outcomes

  1. Outpatient Perinatal Care Visits

    Time frame: Randomization to study completion (up to 34 weeks)

    Number of perinatal care visits

  2. Preterm Birth

    Time frame: At birth

    Delivery of a neonate at less than 37 weeks

  3. Neonatal Birthweight

    Time frame: At birth

    Weight of neonate at birth

  4. Cesarean Delivery

    Time frame: At birth

    Occurrence of a cesarean birth

  5. Maternal Blood Transfusion

    Time frame: At birth

    Transfusion of blood products

  6. Breastfeeding Intent

    Time frame: Upon admission to the delivery-associated hospitalization

    Participant's self-reported intent of whether or not to express breast milk upon admission to the delivery-associated hospitalization

  7. Vaccination Rate

    Time frame: Pregnancy through 6 weeks postpartum / 6 weeks of life

    The number of mothers who received Tdap and infants who received the Hep B vaccine.

  8. Maternal Postpartum Readmission

    Time frame: From discharge from the delivery-associated hospitalization to 6 weeks postpartum

    Admission of the mother to the hospital after discharge from the delivery-associated hospitalization

  9. Neonatal Hospital Readmission

    Time frame: Birth to 6 weeks of life

    Answer to the question " How is your baby doing?"

Sponsors and collaborators

Lead sponsor

University of Alabama at Birmingham

Other

Collaborators

  • American Heart Association
  • ConnectionHealth
  • Memora Health

Registry information

Acronym: PᵌOPPY

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jul 11, 2023
Registry last updated
Oct 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.